A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Children (≥ 4 to < 17 Years of Age) With Epilepsy

Trial Profile

A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Children (≥ 4 to < 17 Years of Age) With Epilepsy

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 03 Oct 2017

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Sponsors UCB
  • Most Recent Events

    • 07 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 22 May 2017 Planned End Date changed from 30 Jun 2020 to 14 Aug 2020.
    • 22 May 2017 Planned primary completion date changed from 30 Jun 2020 to 14 Aug 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top